Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV...

by Thurner, Beatrice, Haendle, Ina, Röder, Claudia, Dieckmann, Detlef, Keikavoussi, Petra, Jonuleit, Helmut, Bender, Armin, Maczek, Christian, Schreiner, Doris, von den Driesch, Peter, Bröcker, Eva B., Steinman, Ralph M., Enk, Alexander, Kämpgen, Eckhart, Schuler, Gerold
Published 1999

Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma

by Becker, Jürgen C., Andersen, Mads H., Hofmeister-Müller, Valeska, Wobser, Marion, Frey, Lidia, Sandig, Christiane, Walter, Steffen, Singh-Jasuja, Harpreet, Kämpgen, Eckhart, Opitz, Andreas, Zapatka, Marc, Bröcker, Eva-B., thor Straten, Per, Schrama, David, Ugurel, Selma
Published 2012

Open-label, multicenter, single-arm phase II DeCOG-study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma

by Zimmer, Lisa, Eigentler, Thomas K., Kiecker, Felix, Simon, Jan, Utikal, Jochen, Mohr, Peter, Berking, Carola, Kämpgen, Eckhart, Dippel, Edgar, Stadler, Rudolf, Hauschild, Axel, Fluck, Michael, Terheyden, Patrick, Rompel, Rainer, Loquai, Carmen, Assi, Zeinab, Garbe, Claus, Schadendorf, Dirk
Published 2015

Phase II DeCOG-Study of Ipilimumab in Pretreated and Treatment-Naïve Patients with Metastatic Uveal Melanoma

by Zimmer, Lisa, Vaubel, Julia, Mohr, Peter, Hauschild, Axel, Utikal, Jochen, Simon, Jan, Garbe, Claus, Herbst, Rudolf, Enk, Alexander, Kämpgen, Eckhart, Livingstone, Elisabeth, Bluhm, Leonie, Rompel, Rainer, Griewank, Klaus G., Fluck, Michael, Schilling, Bastian, Schadendorf, Dirk
Published 2015